AAAAAA

   
Results: 1-11 |
Results: 11
Apparent human BRCAI knockout caused by mispriming during polymerase chainreaction: Implications for genetic testing
Authors: Kuschel, B Gayther, SA Easton, DF Ponder, BAJ Pharoah, PDP
Citation: B. Kuschel et al., Apparent human BRCAI knockout caused by mispriming during polymerase chainreaction: Implications for genetic testing, GENE CHROM, 31(1), 2001, pp. 96-98
Mutations truncating the EP300 acetylase in human cancers
Authors: Gayther, SA Batley, SJ Linger, L Bannister, A Thorpe, K Chin, SF Daigo, Y Russell, P Wilson, A Sowter, HM Delhanty, JDA Ponder, BAJ Kouzarides, T Caldas, C
Citation: Sa. Gayther et al., Mutations truncating the EP300 acetylase in human cancers, NAT GENET, 24(3), 2000, pp. 300-303
Risk models for familial ovarian and breast cancer
Authors: Antoniou, AC Gayther, SA Stratton, JF Ponder, BAJ Easton, DF
Citation: Ac. Antoniou et al., Risk models for familial ovarian and breast cancer, GENET EPID, 18(2), 2000, pp. 173-190
Frequent loss of BRCA1 mRNA and protein expression in sporadic ovarian cancers
Authors: Russell, PA Pharoah, PDP De Foy, K Ramus, SJ Symmonds, I Wilson, A Scott, I Ponder, BAJ Gayther, SA
Citation: Pa. Russell et al., Frequent loss of BRCA1 mRNA and protein expression in sporadic ovarian cancers, INT J CANC, 87(3), 2000, pp. 317-321
Idiopathic slow-transit constipation is not associated with mutations of the RET proto-oncogene or GDNF
Authors: Knowles, CH Gayther, SA Scott, M Ramus, S Anand, P Williams, NS Ponder, BA
Citation: Ch. Knowles et al., Idiopathic slow-transit constipation is not associated with mutations of the RET proto-oncogene or GDNF, DIS COL REC, 43(6), 2000, pp. 851-857
The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer (vol 60, pg 4513, 2000)
Authors: Gayther, SA
Citation: Sa. Gayther, The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer (vol 60, pg 4513, 2000), CANCER RES, 60(24), 2000, pp. 7185-7185
The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer
Authors: Gayther, SA de Foy, EAF Harrington, P Pharoah, P Dunsmuir, WD Edwards, SM Gillett, C Ardern-Jones, A Dearnaley, DP Easton, DF Ford, D Shearer, RJ Kirby, RS Dowe, AL Kelly, J Stratton, MR Ponder, BAJ Barnes, D Eeles, RA
Citation: Sa. Gayther et al., The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer, CANCER RES, 60(16), 2000, pp. 4513-4518
The exon 13 duplication in the BRCA1 gene is a founder mutation present ingeographically diverse populations
Authors: Mazoyer, S Leary, J Kirk, J Fleischmann, E Wagner, T Claes, K Messiaen, L Foulkes, W Desrochers, M Simard, J Phelan, CM Kwan, E Narod, SA Vahteristo, P Nevanlinna, H Durando, X Bignon, YJ Peyrat, JP Bonnardel, C Sinilnikova, OM Puget, N Lenoir, GM Mazoyer, S Audoynaud, C Goldgar, D Maugard, C Caux, V Gad, S Stoppa-Lyonnet, D Nogues, C Lidereau, R Machavoine, C Bressac-de Paillerets, B Kuschel, B Betz, B Niederacher, D Beckmann, MW Hamann, U Gayther, SA Ponder, BAP Robinson, M Taylor, GR Bishop, T Catteau, A Solomon, E Cohen, B Steel, M Collins, N Stratton, M van der Looij, M Olah, E Miller, NJ Barton, DE Sverdlov, RS Friedman, E Radice, P Montagna, M Sensi, E Caligo, M van Eijk, R Devilee, P van der Luijt, R Heimdal, K Moller, P Borg, A Diez, O Cortes, J Domenech, M Baiget, M Osorio, A Benitez, J Borg, A Maillet, P Sappino, AP Ozdag, H Ozcelik, T Ozturk, M Rohlfs, EM Boyd, J McDermott, D Offit, K Unger, M Nathanson, K Weber, BL Sellers, TA Hampton, E Couch, FJ Neuhausen, S
Citation: S. Mazoyer et al., The exon 13 duplication in the BRCA1 gene is a founder mutation present ingeographically diverse populations, AM J HU GEN, 67(1), 2000, pp. 207-212
Increased frequency of TP53 mutations in BRCA1 and BRCA2 ovarian tumours
Authors: Ramus, SJ Bobrow, LG Pharoah, PDP Finnigan, DS Fishman, A Altaras, M Harrington, PA Gayther, SA Ponder, BAJ Friedman, LS
Citation: Sj. Ramus et al., Increased frequency of TP53 mutations in BRCA1 and BRCA2 ovarian tumours, GENE CHROM, 25(2), 1999, pp. 91-96
Familial gastric cancer: overview and guidelines for management
Authors: Caldas, C Carneiro, F Lynch, HT Yokota, J Wiesner, GL Powell, SM Lewis, FR Huntsman, DG Pharoah, PDP Jankowski, JA MacLeod, P Vogelsang, H Keller, G Park, KGM Richards, FM Maher, ER Gayther, SA Oliveira, C Grehan, N Wight, D Seruca, R Roviello, F Ponder, BAJ Jackson, CE
Citation: C. Caldas et al., Familial gastric cancer: overview and guidelines for management, J MED GENET, 36(12), 1999, pp. 873-880
The contribution of germline BRCA1 and BRCA2 mutations to familial ovariancancer: No evidence for other ovarian cancer-susceptibility genes
Authors: Gayther, SA Russell, P Harrington, P Antoniou, AC Easton, DF Ponder, BAJ
Citation: Sa. Gayther et al., The contribution of germline BRCA1 and BRCA2 mutations to familial ovariancancer: No evidence for other ovarian cancer-susceptibility genes, AM J HU GEN, 65(4), 1999, pp. 1021-1029
Risultati: 1-11 |